Elite Pharmaceuticals (ELTP) Cash from Investing Activities (2010 - 2026)
Elite Pharmaceuticals (ELTP) recorded Cash from Investing Activities of -$808,964 in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$218,204 a year earlier.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Cash from Investing Activities (2010 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' Cash from Investing Activities came in at -$1.52 million as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at -$925,626.
- Across earlier fiscal years, Cash from Investing Activities came in at -$2.4 million in FY2025, -$809,653 in FY2024, -$5.74 million in FY2023 and -$498,566 in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly Cash from Investing Activities since fiscal Q1 2025.
- Per Business Quant, the preceding three fiscal quarters came in at -$398,016 (Q4 2026), -$206,072 (Q3 2026) and -$103,334 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | -2.71 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Elite Pharmaceuticals | 269.28 Mn | 150.96 Mn | 13.51 Mn | -808,964.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -808,964.00 |
| Mar 31, 2026 | -398,016.00 |
| Dec 31, 2025 | -206,072.00 |
| Sep 30, 2025 | -103,334.00 |
| Jun 30, 2025 | -218,204.00 |
| Mar 31, 2025 | -754,110.00 |
| Sep 30, 2024 | 17,555.00 |
| Jun 30, 2024 | -1.66 Mn |
| Mar 31, 2024 | -403,646.00 |
| Mar 31, 2023 | -536,211.00 |
| Dec 31, 2022 | -711.00 |
| Sep 30, 2022 | -5.11 Mn |
| Jun 30, 2022 | -94,597.00 |
| Mar 31, 2022 | -264,179.00 |
| Dec 31, 2021 | -82,076.00 |
| Sep 30, 2021 | -147,361.00 |
| Jun 30, 2021 | -4,950.00 |
| Mar 31, 2021 | -184,902.00 |
| Dec 31, 2020 | -37,706.00 |
| Sep 30, 2020 | -77,449.00 |
API Access
Elite Pharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();